Full-Time

Production Test Specialist

Posted on 4/3/2024

Quanterix

Quanterix

201-500 employees

Ultra-sensitive biomarker detection technology

Data & Analytics

Mid

Billerica, MA, USA

Requirements
  • Bachelor's Degree in Chemistry/Biochemistry/Biology/related field; or Scientific Associate Degree with additional years of life science experience
  • 1+ years of QC analytical experience working within the medical device or pharmaceuticals regulated product environment preferred
  • Familiarity with application of FDA and/or ISO quality standards in a government regulated industry preferred
  • ELISA's and other plate-based methods for routine and non-routine use experience preferred
  • Exposure to creation of QC documents and quality events
  • Working knowledge of standard laboratory practices and safety
  • Microbiology experience preferred but not required
  • Preferred to have hands-on experience and demonstrated organisational skills in a regulated analytical environment
  • Demonstrated ability to work well within cross-functional teams as a team player
  • Possess an ability to learn and master complicated concepts quickly and comfortably
  • Ability to generate high quality data under tight deadlines, and a collaborative, proactive attitude
  • Strong attention to detail
  • Strong computer and database skills
Responsibilities
  • Perform bioburden testing on samples from manufacturing, documenting and reporting results
  • Work with quality assurance to develop AQL sampling plan for bioburden testing
  • Develop and maintain standard operating procedures and work instructions for performing bioburden testing
  • Perform maintenance and cleaning of equipment used for bioburden testing
  • Perform/manage daily, weekly, monthly instrument maintenance and cleaning
  • Perform immunoassay testing on automated and semi-automated instrument platforms
  • Perform peer review/approval of test data

Quanterix specializes in Simoa technology, a forefront in ultrasensitive biomarker detection for early disease diagnosis and precise treatment across areas like oncology and neurology. Their scientific rigor and commitment to advancing therapeutic accuracy create a stimulating environment for professionals keen on impactful biotechnological innovation. This setting not only champions industry leadership in medical diagnostics but also fosters a culture prioritizing breakthrough research and patient welfare.

Company Stage

IPO

Total Funding

$559.6M

Headquarters

Billerica, Massachusetts

Founded

2007

Growth & Insights
Headcount

6 month growth

8%

1 year growth

20%

2 year growth

-8%
INACTIVE